SANTINI, ALAN
 Distribuzione geografica
Continente #
EU - Europa 213
NA - Nord America 87
AS - Asia 27
AF - Africa 8
SA - Sud America 6
OC - Oceania 1
Totale 342
Nazione #
IT - Italia 135
US - Stati Uniti d'America 86
DE - Germania 19
GB - Regno Unito 13
IN - India 13
SE - Svezia 11
BR - Brasile 6
SG - Singapore 6
FR - Francia 5
CI - Costa d'Avorio 4
PL - Polonia 4
PT - Portogallo 4
AT - Austria 3
BG - Bulgaria 3
CN - Cina 3
EG - Egitto 3
ES - Italia 3
IE - Irlanda 3
UA - Ucraina 3
DK - Danimarca 2
GR - Grecia 2
VN - Vietnam 2
AU - Australia 1
CA - Canada 1
FI - Finlandia 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
JP - Giappone 1
NL - Olanda 1
TG - Togo 1
Totale 342
Città #
Bologna 37
Chandler 19
Milan 15
Ann Arbor 6
Southend 6
São Paulo 6
Cervia 5
Falls Church 5
Abidjan 4
Delhi 4
Forlì 4
Hyderabad 4
New York 4
Rimini 4
Singapore 4
Stockholm 4
Besenello 3
Boscoreale 3
Cairo 3
Cecina 3
Civitanova Marche 3
Dublin 3
Fairfield 3
Rome 3
Sofia 3
Birkerød 2
Bonn 2
Bremen 2
Calderara di Reno 2
Campobasso 2
Casalecchio di Reno 2
Cesena 2
Coimbra 2
Dresden 2
Florence 2
Houston 2
Kerken 2
Khmelnytskyi 2
Krakow 2
Lucknow 2
Porto 2
Princeton 2
Ravenna 2
Redmond 2
Trento 2
Urbino 2
Valencia 2
Verona 2
Warminster 2
Woodbridge 2
Amman 1
Aquileia 1
Arta 1
Asciano 1
Ashburn 1
Barcelona 1
Beijing 1
Berlin 1
Boydton 1
Böblingen 1
Canberra 1
Canicattì 1
Caserta 1
Chiampo 1
Crevalcore 1
Dallas 1
Fiume Veneto 1
Genova 1
Giromagny 1
Hamm 1
Helsinki 1
Kilburn 1
Lodz 1
Lomé 1
London 1
Los Angeles 1
Middlesbrough 1
New Bedfont 1
Norwalk 1
Palo Del Colle 1
Paris 1
Pozza 1
Pátrai 1
Rocca Pia 1
San Diego 1
San Francisco 1
Sendai 1
Senigallia 1
Southwark 1
Taizhou 1
The Bronx 1
Toronto 1
Utrecht 1
Vienna 1
Wilmington 1
Totale 253
Nome #
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer 162
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 134
PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION 51
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer 13
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 5
Totale 365
Categoria #
all - tutte 1.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 4 1 3 3 3 7 8 4 1 4 9
2021/202235 3 0 1 1 4 4 1 2 4 3 8 4
2022/202376 20 6 1 5 13 8 3 0 11 1 6 2
2023/2024177 12 11 28 13 19 18 10 8 6 8 28 16
2024/202530 25 5 0 0 0 0 0 0 0 0 0 0
Totale 365